Registry Next-Generation-Sequencing (NGS) tests for oncology

The pilot study aims to introduce the NGS technology in our public health system and is realized through an agreement (convention) between (private) laboratories and hospitals and the NIHDI for a reimbursement of NGS tests in oncology and hemato-oncology.本试点研究旨在将下一代测序（Next Generation Sequencing, NGS）技术引入本公共卫生体系，并通过（私立）实验室、医院与NIHDI达成的协议（约定）落地实施，以实现肿瘤学与血液肿瘤学领域NGS检测的费用报销。